Anxiety, depression and cognitive impairment in people with multiple sclerosis (MS)

This article explores the prevalence and impact of anxiety, depression, and cognitive impairment in people with multiple sclerosis (MS), as well as the complex relationships between these three comorbidities. To this end, a systematic review of the relevant scientific literature was conducted. The results of the review indicate an increased prevalence of anxiety and depression in patients with MS, compared with the general population.